News from cirius therapeutics A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

Jun 12, 2019, 08:00 ET Cirius Therapeutics Expands Scientific Advisory Board

Cirius Therapeutics, a clinical-stage pharmaceutical company focused on the development and commercialization of innovative therapies for the...


Jun 05, 2019, 08:00 ET Interim Data on Cirius Therapeutics' MSDC-0602K to be Presented at the American Diabetes Association Scientific Sessions

Cirius Therapeutics, a clinical stage pharmaceutical company focused on the development and commercialization of innovative therapies for the...


Jun 03, 2019, 08:00 ET Cirius Therapeutics Adds to Leadership Team

Cirius Therapeutics, a clinical-stage pharmaceutical company focused on the development and commercialization of innovative therapies for the...


Apr 12, 2019, 11:30 ET Cirius Therapeutics Announces Presentation of Interim Data from Phase 2b Clinical Study of MSDC-0602K at The International Liver Congress 2019

Cirius Therapeutics announced today that positive results from an interim analysis of exploratory endpoints from the EMMINENCE trial, its ongoing...


Mar 27, 2019, 08:00 ET Cirius Therapeutics to Present Preclinical Data for Lead Drug Candidate in NASH at The International Liver Congress

Cirius Therapeutics, a clinical stage pharmaceutical company focused on the development and commercialization of innovative therapies for the...


Dec 13, 2018, 08:00 ET Cirius Therapeutics Expands Board of Directors with Appointment of Elaine D. Sun

Cirius Therapeutics, a clinical-stage pharmaceutical company focused on the development and commercialization of innovative therapies for the...


Nov 06, 2018, 08:00 ET Cirius Therapeutics Announces Two Posters on MSDC-0602K to be Presented at The Liver Meeting 2018

Cirius Therapeutics today announced the presentation of two posters further describing the activity of MSDC-0602K in diet-induced models of...


Oct 25, 2018, 08:00 ET Cirius Therapeutics Reports Positive Data for MSDC-0602K in Interim Analysis of Phase 2b Clinical Trial in NASH Patients with Fibrosis

Cirius Therapeutics today announced positive results from an interim analysis of exploratory endpoints from its ongoing, fully enrolled Phase 2b...


May 02, 2018, 08:00 ET Cirius Therapeutics Reaches Enrollment Target in Phase 2b EMMINENCE Trial in NASH

Cirius Therapeutics announced today that it has reached its enrollment target in its Phase 2b EMMINENCE trial for its lead program MSDC-0602K in more ...


Apr 12, 2018, 08:00 ET Cirius Therapeutics' Preclinical Data Demonstrates Potential for Lead Drug Candidate MSDC-0602K in NASH

Cirius Therapeutics announced today that it presented a late-breaking poster describing the activity of the company's lead drug MSDC-0602K in a...


Mar 29, 2018, 08:00 ET Cirius Therapeutics to Present Late-Breaking Poster at The International Liver Congress

Cirius Therapeutics announced today that it will present a late-breaking poster describing the activity of the company's lead drug MSDC-0602K in a...


Jan 04, 2018, 08:00 ET Cirius Therapeutics Expands Board of Directors with Appointment of Dennis M. Fenton

Cirius Therapeutics, a clinical-stage pharmaceutical company focused on developing therapies to treat liver disease, announced today that Dennis...


Oct 20, 2017, 08:00 ET Cirius Therapeutics to Present Poster at The Liver Meeting 2017

Cirius Therapeutics announced today that it will present a poster describing the activity of the company's lead drug MSDC-0602K in a diet-induced...


Apr 11, 2017, 08:00 ET Cirius Therapeutics Completes $40 Million Series A Financing to Fund Phase 2b Study of MSDC-0602K in NASH, Adds to Executive Team

Cirius Therapeutics, previously known as Octeta Therapeutics, announced today the completion of a Series A financing of up to $40 million led by...